Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
iVeena
company
About
iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.99K
- Industries
- Biotechnology,Clinical Trials,Life Science,Medical Device
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma.iVeena Delivery Systems, Inc. was founded in 2006 by Bala Ambati and is based in Salt Lake City, Utah.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$2.12M
iVeena has raised a total of
$2.12M
in funding over 2 rounds. Their latest funding was raised on
Jul 10, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 10, 2017 | Grant | $224.99K | 1 |
National Science Foundation
|
— | Detail |
| Dec 18, 2015 | Seed | $600K | 2 | — | — | Detail |
| Sep 25, 2015 | Seed | $1.30M | 1 |
Park City Angels
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
iVeena is funded by 3 investors.
National Science Foundation
and Park City Angels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
Park City Angels
|
— | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
